Anhedonia: A Concept Analysis

Archives of Psychiatric Nursing

Volumn 27, Issue 3, 2013, Pages 121-129

  Ho, Nancy ^a   Sommers, Marilyn ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANHEDONIA; HUMAN; MOTIVATION; REVIEW; SATISFACTION;

ANHEDONIA; HUMANS; MOTIVATION; PERSONAL SATISFACTION;

EID: 84878133237     PISSN: 08839417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.apnu.2013.02.001     Document Type: Review

References (99)

1. Agrawal A., Nelson E.C., Littlefield A.K., Bucholz K.K., Degenhardt L., Henders A.K., et al. Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression. Archives of General Psychiatry 2012, 69(7):732-740.
2. Aguera-Ortiz L., Failde I., Mico J.A., Cervilla J., Lopez-Ibor J.J. Pain as a symptom of depression: Prevalence and clinical correlates in patients attending psychiatric clinics. Journal of Affective Disorders 2011, 130(1-2):106-112.
3. Ahnallen C.G., Liverant G.I., Gregor K.L., Kamholz B.W., Levitt J.J., Gulliver S.B., et al. The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia. Psychiatry Research 2012, 196(1):9-14.
4. American Psychiatric Association Diagnostic and statistical manual of mental disorders (4th ed., Text Revision) 2000, Author, Washington, DC.
5. Barch D.M., Dowd E.C. Goal representations and motivational drive in schizophrenia: The role of prefrontal-striatal interactions. Schizophrenia Bulletin 2010, 36(5):919-934.
6. Becerril K., Barch D. Influence of emotional processing on working memory in schizophrenia. Schizophrenia Bulletin 2011, 37(5):1027-1038.
7. Bencherif M., Stachowiak M.K., Kucinski A.J., Lippiello P.M. Alpha7 nicotinic cholinergic neuromodulation may reconcile multiple neurotransmitter hypotheses of schizophrenia. Medical Hypotheses 2012, 78(5):594-600.
8. Berrios G.E., Olivares J.M. The anhedonias: A conceptual history. History of Psychiatry 1995, 6(24 Pt 4):453-470.
9. Blanchard J.J., Collins L.M., Aghevli M., Leung W.W., Cohen A.S. Social anhedonia and schizotypy in a community sample: The Maryland longitudinal study of schizotypy. Schizophrenia Bulletin 2011, 37(3):587-602.
10. Bobo W.V., Woodward N.D., Sim M.Y., Jayathilake K., Meltzer H.Y. The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: A randomized, double-blind, placebo-controlled trial. Schizophrenia Research 2011, 130(1-3):106-113.
11. Bogdan R., Santesso D.L., Fagerness J., Perlis R.H., Pizzagalli D.A. Corticotropin-releasing hormone receptor type 1 (CRHR1) genetic variation and stress interact to influence reward learning. Journal of Neuroscience 2011, 31(37):13246-13254.
12. Britton P.C., Bossarte R.M., Lu N., He H., Currier G.W., Crilly J., et al. Prevalence, correlates, and symptom profiles of depression among men with a history of military service. Social Psychiatry and Psychiatric Epidemiology 2011, 46(7):607-614.
13. Calabro R.S., Italiano D., Militi D., Bramanti P. Levetiracetam-associated loss of libido and anhedonia. Epilepsy & Behavior 2012, 24(2):283-284.
14. Camardese G., De Risio L., Pizi G., Mattioli B., Buccelletti F., Serrani R., et al. Plasma magnesium levels and treatment outcome in depressed patients. Nutritional Neuroscience 2012, 15(2):78-84.
15. Carlezon W.A., Chartoff E.H. Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nature Protocols 2007, 2(11):2987-2995.
16. Chapman H.L., Grimshaw G.M., Nicholls M.E. Going beyond students: An association between mixed-hand preference and schizotypy subscales in a general population. Psychiatry Research 2011, 187(1-2):89-93.
17. Chevallier C., Grezes J., Molesworth C., Berthoz S., Happe F. Brief report: Selective social anhedonia in high functioning autism. Journal of Autism and Developmental Disorders 2012, 42(7):1504-1509.
18. Cohen A.S., Callaway D.A., Najolia G.M., Larsen J.T., Strauss G.P. On "risk" and reward: Investigating state anhedonia in psychometrically defined schizotypy and schizophrenia. Journal of Abnormal Psychology 2012, 121(2):407-415.
19. Cohen A.S., Couture S.M., Blanchard J.J. Neuropsychological functioning and social anhedonia: Three-year follow-up data from a longitudinal community high risk study. Journal of Psychiatric Research 2012, 46(7):898-904.
20. Cohen A.S., Minor K.S. Emotional experience in patients with schizophrenia revisited: Meta-analysis of laboratory studies. Schizophrenia Bulletin 2010, 36(1):143-150.
21. Cohen A.S., Najolia G.M., Brown L.A., Minor K.S. The state-trait disjunction of anhedonia in schizophrenia: Potential affective, cognitive and social-based mechanisms. Clinical Psychology Review 2011, 31(3):440-448.
22. Compton M.T., Frank E. Mental health concerns among Canadian physicians: Results from the 2007-2008 Canadian Physician Health Study. Comprehensive Psychiatry 2011, 52(5):542-547.
23. Couture S.M., Blanchard J.J., Bennett M.E. Negative expectancy appraisals and defeatist performance beliefs and negative symptoms of schizophrenia. Psychiatry Research 2011, 189(1):43-48.
24. de Cock E.S., Emons W.H., Nefs G., Pop V.J., Pouwer F. Dimensionality and scale properties of the Edinburgh Depression Scale (EDS) in patients with type 2 diabetes mellitus: The DiaDDzoB study. BMC Psychiatry 2011, 11:141.
25. Der-Avakian A., Markou A. The neurobiology of anhedonia and other reward-related deficits. Trends in Neurosciences 2012, 35(1):68-77.
26. D'Haenen H. Measurement of anhedonia. European Psychiatry 1996, 11(7):335-343.
27. Dichter G.S. Anhedonia in unipolar major depressive disorder: A review. The Open Psychiatry Journal 2010, 4:1-9.
28. Dinovo S.A., Vasey M.W. Reactive and self-regulatory dimensions of temperament: Interactive relations with symptoms of general distress and anhedonia. Journal of Research in Personality 2011, 45(5):430-440.
29. Dowd E.C., Barch D.M. Pavlovian reward prediction and receipt in schizophrenia: Relationship to anhedonia. PLoS One 2012, 7(5):e35622.
30. Falkenberg I., Kohn N., Schoepker R., Habel U. Mood induction in depressive patients: A comparative multidimensional approach. PLoS One 2012, 7(1):e30016.
31. Forbes E.E., Dahl R.E. Altered reward function in adolescent depression: What, when and how?. Journal of Child Psychology and Psychiatry, and Allied Disciplines 2012, 53(1):3-15.
32. Foussias G., Remington G. Negative symptoms in schizophrenia: Avolition and Occam's razor. Schizophrenia Bulletin 2010, 36(2):359-369.
33. Fujiwara S., Kimura F., Hosokawa T., Ishida S., Sugino M., Hanafusa T. Anhedonia in Japanese patients with Parkinson's disease. Geriatrics and Gerontology International 2011, 11(3):275-281.
34. Gabbay V., Ely B.A., Babb J., Liebes L. The possible role of the kynurenine pathway in anhedonia in adolescents. Journal of Neural Transmission 2012, 119(2):253-260.
35. Gabbay V., Mao X., Klein R.G., Ely B.A., Babb J.S., Panzer A.M., et al. Anterior cingulate cortex gamma-aminobutyric acid in depressed adolescents: relationship to anhedonia. Archives of General Psychiatry 2012, 69(2):139-149.
36. Germine L.T., Garrido L., Bruce L., Hooker C. Social anhedonia is associated with neural abnormalities during face emotion processing. NeuroImage 2011, 58(3):935-945.
37. Goldberg Y., Eastwood J.D., Laguardia J., Danckert J. Boredom: An emotional experience distinct from apathy, anhedonia, or depression. Journal of Social and Clinical Psychology 2011, 30(6):647-666.
38. Gradin V.B., Kumar P., Waiter G., Ahearn T., Stickle C., Milders M., et al. Expected value and prediction error abnormalities in depression and schizophrenia. Brain 2011, 134(Pt 6):1751-1764.
39. Grant P.M., Huh G.A., Perivoliotis D., Stolar N.M., Beck A.T. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia. Archives of General Psychiatry 2012, 69(2):121-127.
40. Grillo L. Might the inability to feel pleasure (anhedonia) explain the symptoms of major depression and schizophrenia, including unmotivated anxiety, delusions and hallucinations?. Medical Hypotheses 2012, 78(1):98-101.
41. Hannestad J., DellaGioia N., Ortiz N., Pittman B., Bhagwagar Z. Citalopram reduces endotoxin-induced fatigue. Brain, Behavior, and Immunity 2011, 25(2):256-259.
42. Hitsman B., Buka S.L., Veluz-Wilkins A.K., Mohr D.C., Niaura R., Gilman S.E. Accuracy of a brief screening scale for lifetime major depression in cigarette smokers. Psychology of Addictive Behaviors 2011, 25(3):559-564.
43. Ho N., Balu D.T., Hilario M.R., Blendy J.A., Lucki I. Depressive phenotypes evoked by experimental diabetes are reversed by insulin. Physiology and Behavior 2012, 105(3):702-708.
44. Horan W.P., Kring A.M., Gur R.E., Reise S.P., Blanchard J.J. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS). Schizophrenia Research 2011, 132(2-3):140-145.
45. Keedwell P.A., Andrew C., Williams S.C., Brammer M.J., Phillips M.L. The neural correlates of anhedonia in major depressive disorder. Biological Psychiatry 2005, 58(11):843-853.
46. Kirkpatrick B., Strauss G.P., Nguyen L., Fischer B.A., Daniel D.G., Cienfuegos A., et al. The brief negative symptom scale: Psychometric properties. Schizophrenia Bulletin 2011, 37(2):300-305.
47. Kober H., Ochsner K.N. Regulation of emotion in major depressive disorder. Biological Psychiatry 2011, 70(10):910-911.
48. Komulainen T., Keranen A.M., Rasinaho E., Hakko H., Savolainen M.J., Kujari M.L., et al. Quitting a weight loss program is associated with anhedonia: Preliminary findings of the Lifestyle Intervention Treatment Evaluation Study in northern Finland. International Journal of Circumpolar Health 2011, 70(1):72-78.
49. Koolhaas J.M., Bartolomucci A., Buwalda B., de Boer S.F., Flugge G., Korte S.M., et al. Stress revisited: A critical evaluation of the stress concept. Neuroscience and Biobehavioral Reviews 2011, 35(5):1291-1301.
50. Kring A.M., Moran E.K. Emotional response deficits in schizophrenia: Insights from affective science. Schizophrenia Bulletin 2008, 34(5):819-834.
51. Kuba T., Yakushi T., Fukuhara H., Nakamoto Y., Singeo S.T., Tanaka O., et al. Suicide-related events among child and adolescent patients during short-term antidepressant therapy. Psychiatry and Clinical Neurosciences 2011, 65(3):239-245.
52. Lee J.S., Park H.J., Chun J.W., Seok J.H., Park I.H., Park B., et al. Neuroanatomical correlates of trait anhedonia in patients with schizophrenia: A voxel- based morphometric study. Neuroscience Letters 2011, 489(2):110-114.
53. Liemburg E., Aleman A., Bous J., Hollander K., Knegtering H. An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being. Pharmacopsychiatry 2011, 44(3):109-113.
54. Light S.N., Heller A.S., Johnstone T., Kolden G.G., Peterson M.J., Kalin N.H., et al. Reduced right ventrolateral prefrontal cortex activity while inhibiting positive affect is associated with improvement in hedonic capacity after 8 weeks of antidepressant treatment in major depressive disorder. Biological Psychiatry 2011, 70(10):962-968.
55. Martin E.A., Becker T.M., Cicero D.C., Docherty A.R., Kerns J.G. Differential associations between schizotypy facets and emotion traits. Psychiatry Research 2011, 187(1-2):94-99.
56. Martinotti G., Andreoli S., Reina D., Di Nicola M., Ortolani I., Tedeschi D., et al. Acetyl-l-carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2011, 35(4):953-958.
57. McMakin D.L., Olino T.M., Porta G., Dietz L.J., Emslie G., Clarke G., et al. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. Journal of the American Academy of Child and Adolescent Psychiatry 2012, 51(4):404-411.
58. Meehl P.E. Toward an integrated theory of schizotaxia, schizotypy, and schizophrenia. Journal of Personality Disorders 1990, 4:1-99.
59. Messinger J.W., Tremeau F., Antonius D., Mendelsohn E., Prudent V., Stanford A.D., et al. Avolition and expressive deficits capture negative symptom phenomenology: Implications for DSM-5 and schizophrenia research. Clinical Psychology Review 2011, 31(1):161-168.
60. Miettunen J., Veijola J., Isohanni M., Paunio T., Freimer N., Jaaskelainen E., et al. Identifying schizophrenia and other psychoses with psychological scales in the general population. The Journal of Nervous and Mental Disease 2011, 199(4):230-238.
61. Miura S., Kida H., Nakajima J., Noda K., Nagasato K., Ayabe M., et al. Anhedonia in Japanese patients with Parkinson's disease: Analysis using the Snaith- Hamilton Pleasure Scale. Clinical Neurology and Neurosurgery 2012, 114(4):352-355.
62. Mora P.A., Beamon T., Preuitt L., DiBonaventura M., Leventhal E.A., Leventhal H. Heterogeneity in depression symptoms and health status among older adults. Journal of Aging and Health 2012, 24(5):879-896.
63. Nefs G., Pouwer F., Denollet J., Kramer H., Wijnands-van Gent C.J., Pop V.J. Suboptimal glycemic control in type 2 diabetes: A key role for anhedonia?. Journal of Psychiatric Research 2012, 46(4):549-554.
64. Nefs G., Pouwer F., Pop V., Denollet J. Type D (distressed) personality in primary care patients with type 2 diabetes: Validation and clinical correlates of the DS14 assessment. Journal of Psychosomatic Research 2012, 72(4):251-257.
65. Ossewaarde L., Verkes R.J., Hermans E.J., Kooijman S.C., Urner M., Tendolkar I., et al. Two-week administration of the combined serotonin-noradrenaline reuptake inhibitor duloxetine augments functioning of mesolimbic incentive processing circuits. Biological Psychiatry 2011, 70:568-574.
66. Park S.G., Llerena K., McCarthy J.M., Couture S.M., Bennett M.E., Blanchard J.J. Screening for negative symptoms: Preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms. Schizophrenia Research 2012, 135(1-3):139-143.
67. Pelizza L., Ferrari A. Anhedonia in schizophrenia and major depression: State or trait?. Annals of General Psychiatry 2009, 8:22.
68. Pelle A.J., Pedersen S.S., Erdman R.A., Kazemier M., Spiering M., van Domburg R.T., et al. Anhedonia is associated with poor health status and more somatic and cognitive symptoms in patients with coronary artery disease. Quality of Life Research 2011, 20(5):643-651.
69. Pittman J.O., Goldsmith A.A., Lemmer J.A., Kilmer M.T., Baker D.G. Post- traumatic stress disorder, depression, and health-related quality of life in OEF/OIF veterans. Quality of Life Research 2012, 21(1):99-103.
70. Pizzagalli D.A., Jahn A.L., O'Shea J.P. Toward an objective characterization of an anhedonic phenotype: A signal-detection approach. Biological Psychiatry 2005, 57(4):319-327.
71. Rassovsky Y., Horan W.P., Lee J., Sergi M.J., Green M.F. Pathways between early visual processing and functional outcome in schizophrenia. Psychological Medicine 2011, 41(3):487-497.
72. Reise S.P., Horan W.P., Blanchard J.J. The challenges of fitting an item response theory model to the Social Anhedonia Scale. Journal of Personality Assessment 2011, 93(3):213-224.
73. Ritsner M.S., Arbitman M., Lisker A. Anhedonia is an important factor of health- related quality-of-life deficit in schizophrenia and schizoaffective disorder. The Journal of Nervous and Mental Disease 2011, 199(11):845-853.
74. Robinson O.J., Cools R., Carlisi C.O., Sahakian B.J., Drevets W.C. Ventral striatum response during reward and punishment reversal learning in unmedicated major depressive disorder. The American Journal of Psychiatry 2012, 169(2):152-159.
75. Rodrigo M.J., Leon I., Quinones I., Lage A., Byrne S., Bobes M.A. Brain and personality bases of insensitivity to infant cues in neglectful mothers: An event-related potential study. Development and Psychopathology 2011, 23(1):163-176.
76. Rose E.J., Ross T.J., Salmeron B.J., Lee M., Shakleya D.M., Huestis M., et al. Chronic exposure to nicotine is associated with reduced reward-related activity in the striatum but not the midbrain. Biological Psychiatry 2012, 71(3):206-213.
77. Rubin D.H. Joy returns last: Anhedonia and treatment resistance in depressed adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 2012, 51(4):353-355.
78. Shankman S.A., Sarapas C., Klein D.N. The effect of pre- vs. post-reward attainment on EEG asymmetry in melancholic depression. International Journal of Psychophysiology 2011, 79(2):287-295.
79. Sherdell L., Waugh C.E., Gotlib I.H. Anticipatory pleasure predicts motivation for reward in major depression. Journal of Abnormal Psychology 2012, 121(1):51-60.
80. Shomaker L.B., Tanofsky-Kraff M., Zocca J.M., Field S.E., Drinkard B., Yanovski J.A. Depressive symptoms and cardiorespiratory fitness in obese adolescents. Journal of Adolescent Health 2012, 50(1):87-92.
81. Sibon I., Lassalle-Lagadec S., Renou P., Swendsen J. Evolution of depression symptoms following stroke: A prospective study using computerized ambulatory monitoring. Cerebrovascular Diseases 2012, 33(3):280-285.
82. Smoski M.J., Felder J., Bizzell J., Green S.R., Ernst M., Lynch T.R., et al. fMRI of alterations in reward selection, anticipation, and feedback in major depressive disorder. Journal of Affective Disorders 2009, 118(1-3):69-78.
83. Soliman A., O'Driscoll G.A., Pruessner J., Joober R., Ditto B., Streicker E., et al. Limbic response to psychosocial stress in schizotypy: A functional magnetic resonance imaging study. Schizophrenia Research 2011, 131(1-3):184-191.
84. Steer R.A. Self-reported inability to cry as a symptom of anhedonic depression in outpatients with a major depressive disorder. Psychological Reports 2011, 108(3):874-882.
85. Steffenhagen N., Kurstein B., Kirkby K.C., Himmerich H. Combination of lithium and duloxetine in 2 depressed patients refractory to duloxetine monotherapy. Pharmacopsychiatry 2011, 44(2):72-74.
86. Strauss G.P., Frank M.J., Waltz J.A., Kasanova Z., Herbener E.S., Gold J.M. Deficits in positive reinforcement learning and uncertainty-driven exploration are associated with distinct aspects of negative symptoms in schizophrenia. Biological Psychiatry 2011, 69(5):424-431.
87. Strauss G.P., Gold J.M. A new perspective on anhedonia in schizophrenia. The American Journal of Psychiatry 2012, 169(4):364-373.
88. Strauss G.P., Herbener E.S. Patterns of emotional experience in schizophrenia: Differences in emotional response to visual stimuli are associated with clinical presentation and functional outcome. Schizophrenia Research 2011, 128(1-3):117-123.
89. Strauss G.P., Wilbur R.C., Warren K.R., August S.M., Gold J.M. Anticipatory vs. consummatory pleasure. What is the nature of hedonic deficits in schizophrenia?. Psychiatry Research 2011, 187(1-2):36-41.
90. Tran P., Skolnick P., Czobor P., Huang N.Y., Bradshaw M., McKinney A., et al. Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Journal of Psychiatric Research 2012, 46(1):64-71.
91. Treadway M.T., Zald D.H. Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neuroscience and Biobehavioral Reviews 2011, 35(3):537-555.
92. Tully P.J., Baker R.A. Depression, anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: A contemporary and practical review. Journal of Geriatric Cardiology 2012, 9(2):197-208.
93. Tully L.M., Lincoln S.H., Hooker C.I. Impaired executive control of emotional information in social anhedonia. Psychiatry Research 2012, 197(1-2):29-35.
94. Ursu S., Kring A.M., Gard M.G., Minzenberg M.J., Yoon J.H., Ragland J.D., et al. Prefrontal cortical deficits and impaired cognition-emotion interactions in schizophrenia. The American Journal of Psychiatry 2011, 168(3):276-285.
95. Velthorst E., Meijer C. The association between social anhedonia, withdrawal and psychotic experiences in general and high-risk populations. Schizophrenia Research 2012, 138(2-3):290-294.
96. Walker L.O., Avant K.C. Strategies for theory construction in nursing 2010, Pearson/Prentice Hall, Upper Saddle River, NJ. 5th ed.
97. Wechsler-Zimring A., Kearney C.A. Posttraumatic stress and related symptoms among neglected and physically and sexually maltreated adolescents. Journal of Traumatic Stress 2011, 24(5):601-604.
98. Winterstein B.P., Silvia P.J., Kwapil T.R., Kaufman J.C., Reiter-Palmon R., Wigert B. Brief assessment of schizotypy: Developing short forms of the Wisconsin Schizotypy Scales. Personality and Individual Differences 2011, (51):920-924.
99. Yan C., Liu W.H., Cao Y., Chan R.C. Self-reported pleasure experience and motivation in individuals with schizotypal personality disorders proneness. East Asian Archives of Psychiatry 2011, 21(3):115-122.